Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Gaucher Disease Outcome Survey (GOS)

include to evaluate the safety and long-term effectiveness of velaglucerase alfa, to characterize patients receiving velaglucerase alfa or other Gaucher Disease-specific treatments, to gain a better

velaglucerase alfa
  • 131 views
  • 30 Jan, 2022
  • 1 location
Survey Study for Velaglucerase Alfa (VPRIV) in Japan

The objective of this post-marketing survey study is to collect data to determine the safety and efficacy of velaglucerase alfa (VPRIV) in participants with Gaucher disease who are new to

vpriv
velaglucerase alfa
  • 74 views
  • 12 Feb, 2022
  • 31 locations
Post Marketing Surveillance (PMS) Study for Velaglucerase Alfa (VPRIV) in India

The purpose of this post-marketing survey study is to determine the safety and evaluate effectiveness in participants receiving VPRIV when used in the post-marketing setting and to collect and record genetic mutation data from participants with Gaucher disease.

vpriv
velaglucerase alfa
  • 0 views
  • 21 Aug, 2021
  • 2 locations
A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease

The main aim of this study is to learn if velaglucerase alfa (VPRIV) improves growth and symptoms in participants under 5 years old with Gaucher disease. Symptoms will be checked with blood

vpriv
velaglucerase alfa
  • 0 views
  • 20 Jul, 2021
  • 1 location